✦ LIBER ✦

Efficacy and tolerability of switching from olanzapine, risperidone and haloperidol to ziprasidone in patients with schizophrenia: An international multi-center study

✍ Scribed by K. Alptekin; O.N. Karayal; S. Brook; C. Akkaya; E. Tzebelikos

Book ID: 118439643
Publisher: Elsevier Science
Year: 2008
Tongue: French
Weight: 64 KB
Volume: 23
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2008.01.811

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of quetiapine

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

✍ Ilkka Larmo; André de Nayer; Elmar Windhager; Irmansyah; Bernhard Lindenbauer; H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract A __post hoc__ analysis of the SPECTRUM trial was carried out to evaluate whether the improvements in efficacy and tolerability gained on switching to quetiapine occurred consistently for patients previously treated with either: haloperidol (__n__ = 43); olanzapine (__n__ = 66); or risp

A comparison of the efficacy and safety

A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration

✍ C. W. Ritchie; E. Chiu; S. Harrigan; S. Macfarlane; M. Mastwyk; G. Halliday; H. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 3 views

Background Following an earlier study in which elderly patients with schizophrenia had their typical antipsychotic medication changed to olanzapine or risperidone, the 61 patients were followed for up to a further six months to see if either treatment was superior in terms of efficacy or side effect

Predictors of adherence to atypical anti

Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3½ years duration

✍ C. W. Ritchie; S. Harrigan; M. Mastwyk; S. Macfarlane; N. Cheesman; D. Ames 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

## Abstract ## Objective Although the evidence base for the use of antipsychotics in older people with schizophrenia is generally of low quality, it tends to support the use of atypical antipsychotics. Only limited information regarding longer term adherence to these apparently more effective drug

Open, multi-center, phase IV study to as

Open, multi-center, phase IV study to assess the efficacy and tolerability of triptorelin in Taiwanese patients with advanced prostate cancer

✍ Chien-Chang Kao; Yen-Hwa Chang; Tony Wu; Guang-Huan Sun; Dah-Shyong Yu; Sun-Yran 📂 Article 📅 2012 🏛 Elsevier Science 🌐 Chinese ⚖ 361 KB

The impact upon extra-pyramidal side eff

The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia

✍ C. W. Ritchie; E. Chiu; S. Harrigan; K. Hall; A. Hassett; S. Macfarlane; M. Mast 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## Abstract ## Background Atypical antipsychotics are commonly used in the management of schizophrenia in late life with evidence suggesting they induce lower rates of motor disturbance, but have similar efficacy to conventional antipsychotics. Trials in the elderly have been either retrospective,

An unblinded comparison of the clinical

An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia

✍ Hidenobu Suzuki; Keishi Gen; Yuichi Inoue 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 198 KB